Key Statistics
About Prime Medicine, Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Nov 11, 2025 | Citigroup | |
| Nov 10, 2025 | Chardan Capital |